Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000486673 | SCV000570367 | likely benign | not provided | 2019-04-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000652813 | SCV000774685 | likely benign | Noonan syndrome 9 | 2023-11-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002455928 | SCV002613364 | uncertain significance | Cardiovascular phenotype | 2024-10-08 | criteria provided, single submitter | clinical testing | The p.A1195V variant (also known as c.3584C>T), located in coding exon 23 of the SOS2 gene, results from a C to T substitution at nucleotide position 3584. The alanine at codon 1195 is replaced by valine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Ce |
RCV000486673 | SCV004134076 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | SOS2: BP4 |